Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zalifrelimab by Agenus for Cervical Cancer: Likelihood of Approval
Zalifrelimab is under clinical development by Agenus and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II...
Zalifrelimab by Agenus for Solid Tumor: Likelihood of Approval
Zalifrelimab is under clinical development by Agenus and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
Zalifrelimab by Agenus for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma): Likelihood of Approval
Zalifrelimab is under clinical development by Agenus and currently in Phase II for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). According to...
Zalifrelimab by Agenus for Dedifferentiated Liposarcoma: Likelihood of Approval
Zalifrelimab is under clinical development by Agenus and currently in Phase II for Dedifferentiated Liposarcoma. According to GlobalData, Phase II...
Zalifrelimab by Agenus for Myxoid Liposarcoma: Likelihood of Approval
Zalifrelimab is under clinical development by Agenus and currently in Phase II for Myxoid Liposarcoma. According to GlobalData, Phase II...
Zalifrelimab by Agenus for Round Cell Liposarcoma: Likelihood of Approval
Zalifrelimab is under clinical development by Agenus and currently in Phase II for Round Cell Liposarcoma. According to GlobalData, Phase...
Zalifrelimab by Agenus for Pleomorphic Liposarcoma: Likelihood of Approval
Zalifrelimab is under clinical development by Agenus and currently in Phase II for Pleomorphic Liposarcoma. According to GlobalData, Phase II...
Zalifrelimab by Agenus for Fibrosarcoma: Likelihood of Approval
Zalifrelimab is under clinical development by Agenus and currently in Phase II for Fibrosarcoma. According to GlobalData, Phase II drugs...
Zalifrelimab by Agenus for Synovial Sarcoma: Likelihood of Approval
Zalifrelimab is under clinical development by Agenus and currently in Phase II for Synovial Sarcoma. According to GlobalData, Phase II...